Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | P2RY1 | P47900 | 7/20 | 1.00 |
| ▸ | P2RY2 | P41231 | 3/20 | 1.00 |
| ▸ | P2RX1 | P51575 | 3/20 | 1.00 |
| ▸ | P2RX3 | P56373 | 3/20 | 1.00 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 1.00 |
| ▸ | SRC | P12931 | 2/20 | 1.00 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 1.00 |
| ▸ | P2RX2 | Q9UBL9 | 2/20 | 1.00 |
| ▸ | P2RX4 | Q99571 | 1/20 | 1.00 |
| ▸ | TRPM2 | O94759 | 2/20 | 0.93 |
| ▸ | MACROD2 | A1Z1Q3 | 1/20 | 0.93 |
| ▸ | SIRT6 | Q8N6T7 | 1/20 | 0.93 |
| ▸ | MACROD1 | Q9BQ69 | 1/20 | 0.93 |
| ▸ | TAS1R3 | Q7RTX0 | 2/20 | 0.85 |
| ▸ | TAS1R1 | Q7RTX1 | 2/20 | 0.85 |
| ▸ | DNPH1 | O43598 | 1/20 | 0.85 |
| ▸ | PRKAB2 | O43741 | 1/20 | 0.85 |
| ▸ | LDHA | P00338 | 1/20 | 0.85 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.85 |
| ▸ | FBP1 | P09467 | 1/20 | 0.85 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1744586 | 1.00 | P2RY1 (1.00) | P2RY1P2RY2P2RX1P2RX3ALDH1A1 | |
| Diadenosine Tetraphosphate SCHEMBL849869 | 1.00 | P2RY1 (1.00) | P2RY1P2RY2P2RX1P2RX3ALDH1A1 | |
| SCHEMBL6516963 | 1.00 | P2RY1 (1.00) | P2RY1P2RY2P2RX1P2RX3ALDH1A1 | |
| Diadenosine Tetraphosphate SCHEMBL10069136 | 1.00 | P2RY1 (1.00) | P2RY1P2RY2P2RX1P2RX3ALDH1A1 | |
| Diadenosine Tetraphosphate SCHEMBL4363130 | 1.00 | P2RY1 (1.00) | P2RY1P2RY2P2RX1P2RX3ALDH1A1 | |
| SCHEMBL4357990 | 1.00 | P2RY1 (1.00) | P2RY1P2RY2P2RX1P2RX3ALDH1A1 | |
| Diadenosine Tetraphosphate SCHEMBL14205963 | 1.00 | P2RY1 (1.00) | P2RY1P2RY2P2RX1P2RX3ALDH1A1 | |
| SCHEMBL2934890 | 1.00 | P2RY1 (1.00) | P2RY1P2RY2P2RX1P2RX3ALDH1A1 | |
| Diadenosine Tetraphosphate SCHEMBL4069414 | 1.00 | P2RY1 (1.00) | P2RY1P2RY2P2RX1P2RX3ALDH1A1 | |
| SCHEMBL21067711 | 1.00 | P2RY1 (1.00) | P2RY1P2RY2P2RX1P2RX3ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 160 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026101948-A1 | METHODS AND MATERIALS FOR TREATING CANCER | MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH (US) | 2026-05-15 | — | — | WO | claimed |
| EP-4680739-A1 | SELECTIVE DELIVERY OF ONCO-SUPPRESSIVE MIRNA (MIR126) TO METASTATIC MELANOMA CELLS RESISTANT TO THERAPIES | Istituto Superiore di Sanità (IT) | 2026-01-21 | — | — | EP | claimed |
| WO-2024189572-A1 | SELECTIVE DELIVERY OF ONCO-SUPPRESSIVE MIRNA (MIR126) TO METASTATIC MELANOMA CELLS RESISTANT TO THERAPIES | ISTITUTO SUPERIORE DI SANITA' (IT) | 2024-09-19 | — | — | WO | claimed |
| CN-114391045-A | Internal standard gene | 公立大学法人福岛县立医科大学 | 2022-04-22 | — | — | CN | claimed |
| CN-114127314-A | Genetic genomes, methods and kits for identifying or classifying subtypes (subtypes) of breast cancer | 公立大学法人福岛县立医科大学 | 2022-03-01 | — | — | CN | claimed |
| WO-2026101948-A1 | METHODS AND MATERIALS FOR TREATING CANCER | MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH (US) | 2026-05-15 | — | — | WO | disclosed |
| US-20260136663-A1 | SEMICONDUCTOR DEVICES | SAMSUNG ELECTRONICS CO LTD (KR) | 2026-05-14 | — | — | US | disclosed |
| CN-122028500-A | Semiconductor device with a semiconductor device having a plurality of semiconductor chips | 三星电子株式会社 | 2026-05-12 | — | — | CN | disclosed |
| EP-4739022-A1 | SEMICONDUCTOR DEVICE INCLUDING ACTIVE PORTION AND BIT LINE | Samsung Electronics Co., Ltd. (KR) | 2026-05-06 | — | — | EP | disclosed |
| US-12618044-B2 | Specification of functional cranial placode derivatives from human pluripotent stem cells | MEMORIAL SLOAN-KETTERING CANCER CENTER (US) | 2026-05-05 | — | — | US | disclosed |
| US-20260122885-A1 | SEMICONDUCTOR DEVICE INCLUDING ACTIVE PORTION AND BIT LINE | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2026-04-30 | — | — | US | disclosed |
| US-12612648-B2 | Production method for genome-edited cells | KYUSHU UNIVERSITY, NATIONAL UNIVERSITY CORPORATION (JP) | 2026-04-28 | — | — | US | disclosed |
| CN-114127314-A | Genetic genomes, methods and kits for identifying or classifying subtypes (subtypes) of breast cancer | 公立大学法人福岛县立医科大学 | 2022-03-01 | — | — | CN | disclosed |
| CN-114126613-A | Methods and compositions for modulating splicing | 斯基霍克疗法公司 | 2022-03-01 | — | — | CN | disclosed |
| US-20220042027-A1 | FRUIT-SPECIFIC PROMOTERS | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF AGRICULTURE | 2022-02-10 | — | — | US | disclosed |
| EP-3951517-A1 | UNIT, UNIT CONTROL METHOD, AND UNIT CONTROL PROGRAM | OMRON CORPORATION (JP) | 2022-02-09 | — | — | EP | disclosed |
| CN-114007611-A | Methods and compositions for modulating splicing | 斯基霍克疗法公司 | 2022-02-01 | — | — | CN | disclosed |
| CN-114007612-A | Methods and compositions for modulating splicing | 斯基霍克疗法公司 | 2022-02-01 | — | — | CN | disclosed |
| CN-114007613-A | Methods and compositions for modulating splicing | 斯基霍克疗法公司 | 2022-02-01 | — | — | CN | disclosed |
| CN-114007614-A | Methods and compositions for modulating splicing | 斯基霍克疗法公司 | 2022-02-01 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260136663-A1 | SEMICONDUCTOR DEVICES | NOTCH4, CD47, EPCAM | P2RY1 2386/4885P2RY2 1668/4885P2RX1 1560/4885 |
| US-20260122885-A1 | SEMICONDUCTOR DEVICE INCLUDING ACTIVE PORTION AND BIT LINE | RICTOR, SETD1B, BMI1 | P2RY1 3002/4885P2RY2 2578/4885P2RX1 1993/4885 |
| US-12612648-B2 | Production method for genome-edited cells | ADAR, AMPD1, ADA | P2RY1 4267/4885P2RY2 4443/4885P2RX1 4018/4885 |
| US-12618044-B2 | Specification of functional cranial placode derivatives from human pluripotent stem cells | BMP4, BMP1, PROX1 | P2RY1 2510/4885P2RY2 2731/4885P2RX1 2321/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.